89bio Inc. (ETNB) NASDAQ
$3.47 -0.15 (-4.14%)
Market Cap: $70.62M
As of 06/24/22 04:00 PM EDT. Market closed.

89bio Inc. (ETNB) NASDAQ
$3.47 -0.15 (-4.14%)
Market Cap: $70.62M
As of 06/24/22 04:00 PM EDT. Market closed.
89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, BIO89-100, is a specifically engineered glycoPEGylated analog of FGF21. BIO89-100 is being developed for the treatment of nonalcoholic steatohepatitis (NASH) and severe ... read more
89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, BIO89-100, is a specifically engineered glycoPEGylated analog of FGF21. BIO89-100 is being developed for the treatment of nonalcoholic steatohepatitis (NASH) and severe hypertriglyceridemia (SHTG). 89bio is headquartered in San Francisco with operations in Herzliya, Israel. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Mansbach Harry H | Chief Medical Officer | Feb 05, 2022 | Option Exercise | $5.23 | 1,363 | 7,128 | 31,137 | Apr 13, 2022, 04:05 PM |
Martins Ryan | Chief Financial Officer | Feb 05, 2022 | Option Exercise | $5.23 | 1,022 | 5,345 | 22,478 | Apr 13, 2022, 04:05 PM |
PALEKAR ROHAN | Chief Executive Officer | Feb 05, 2022 | Option Exercise | $5.23 | 4,088 | 21,380 | 95,957 | Apr 13, 2022, 04:05 PM |
Le-Nguyen Quoc | See Remarks | Feb 05, 2022 | Option Exercise | $5.23 | 1,363 | 7,128 | 31,137 | Apr 13, 2022, 04:05 PM |
Waisbourd Ram | See Remarks | Feb 01, 2022 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Feb 03, 2022, 04:30 PM |
Waisbourd Ram | See Remarks | Feb 01, 2022 | Sale | $5.70 | 7,000 | 39,900 | 0 | Feb 03, 2022, 04:30 PM |
PALEKAR ROHAN | Chief Executive Officer | Jan 27, 2022 | Buy | $7.50 | 5,000 | 37,500 | 43,345 | Jan 31, 2022, 04:30 PM |
PALEKAR ROHAN | Chief Executive Officer | Jan 28, 2022 | Buy | $6.14 | 2,500 | 15,350 | 45,845 | Jan 31, 2022, 04:30 PM |
ORBIMED ADVISORS LLC | 10% Owner | Jan 26, 2022 | Sale | $8.38 | 21,482 | 180,019 | 1,829,436 | Jan 27, 2022, 05:22 PM |
ORBIMED ADVISORS LLC | 10% Owner | Jan 25, 2022 | Sale | $8.40 | 49,091 | 412,364 | 1,840,176 | Jan 27, 2022, 05:22 PM |
Waisbourd Ram | See Remarks | Dec 16, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Dec 20, 2021, 04:30 PM |
Waisbourd Ram | See Remarks | Dec 16, 2021 | Sale | $11.48 | 7,000 | 80,360 | 0 | Dec 20, 2021, 04:30 PM |
Waisbourd Ram | See Remarks | Nov 16, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Nov 18, 2021, 06:37 PM |
Waisbourd Ram | See Remarks | Nov 16, 2021 | Sale | $16.49 | 7,000 | 115,430 | 0 | Nov 18, 2021, 06:37 PM |
Waisbourd Ram | See Remarks | Oct 18, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Oct 20, 2021, 04:30 PM |
Waisbourd Ram | See Remarks | Oct 18, 2021 | Sale | $17.49 | 7,000 | 122,430 | 0 | Oct 20, 2021, 04:30 PM |
Waisbourd Ram | See Remarks | Sep 16, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Sep 20, 2021, 04:32 PM |
Waisbourd Ram | See Remarks | Sep 16, 2021 | Sale | $19.46 | 7,000 | 136,220 | 0 | Sep 20, 2021, 04:32 PM |
Waisbourd Ram | See Remarks | Aug 16, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Aug 18, 2021, 04:10 PM |
Waisbourd Ram | See Remarks | Aug 16, 2021 | Sale | $18.28 | 7,000 | 127,960 | 0 | Aug 18, 2021, 04:10 PM |
Waisbourd Ram | See Remarks | Jul 16, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Jul 19, 2021, 04:05 PM |
Waisbourd Ram | See Remarks | Jul 16, 2021 | Sale | $16.80 | 7,000 | 117,600 | 0 | Jul 19, 2021, 04:05 PM |
PALEKAR ROHAN | Chief Executive Officer | Jul 07, 2021 | Buy | $17.07 | 5,000 | 85,350 | 35,000 | Jul 08, 2021, 04:05 PM |
PALEKAR ROHAN | Chief Executive Officer | Jul 08, 2021 | Buy | $16.25 | 2,000 | 32,500 | 37,000 | Jul 08, 2021, 04:05 PM |
RA CAPITAL MANAGEMENT, L.P. | Director | Jun 02, 2021 | Buy | $18.77 | 22,138 | 415,530 | 4,965,769 | Jun 04, 2021, 04:31 PM |
Grunberg Gregory | Director | Apr 21, 2021 | Sale | $27.60 | 850 | 23,460 | 0 | Apr 23, 2021, 05:27 PM |
Waisbourd Ram | See Remarks | Mar 16, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Mar 17, 2021, 04:30 PM |
Waisbourd Ram | See Remarks | Mar 16, 2021 | Sale | $24.20 | 7,000 | 169,400 | 0 | Mar 17, 2021, 04:30 PM |
Hayden Michael R | Director | Feb 23, 2021 | Option Exercise | $2.13 | 80,904 | 172,236 | 80,904 | Feb 25, 2021, 05:01 PM |
Waisbourd Ram | See Remarks | Feb 16, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Feb 17, 2021, 04:22 PM |
Waisbourd Ram | See Remarks | Feb 16, 2021 | Sale | $23.39 | 7,000 | 163,730 | 0 | Feb 17, 2021, 04:22 PM |
Waisbourd Ram | See Remarks | Jan 19, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Jan 20, 2021, 04:30 PM |
Waisbourd Ram | See Remarks | Jan 19, 2021 | Sale | $21.16 | 7,000 | 148,120 | 0 | Jan 20, 2021, 04:30 PM |
Waisbourd Ram | See Remarks | Dec 16, 2020 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Dec 18, 2020, 05:00 PM |
Waisbourd Ram | See Remarks | Dec 16, 2020 | Sale | $27.04 | 7,000 | 189,280 | 0 | Dec 18, 2020, 05:00 PM |
Le-Nguyen Quoc | See Remarks | Nov 16, 2020 | Option Exercise | $3.11 | 4,548 | 14,144 | 4,548 | Nov 18, 2020, 04:00 PM |
Le-Nguyen Quoc | See Remarks | Nov 16, 2020 | Sale | $28.11 | 4,548 | 127,844 | 0 | Nov 18, 2020, 04:00 PM |
Waisbourd Ram | COO and Chief Business Officer | Nov 16, 2020 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Nov 18, 2020, 04:00 PM |
Waisbourd Ram | COO and Chief Business Officer | Nov 16, 2020 | Sale | $27.39 | 7,000 | 191,730 | 0 | Nov 18, 2020, 04:00 PM |
ORBIMED ADVISORS LLC | Director | Sep 21, 2020 | Sale | $28.00 | 275,000 | 7,700,000 | 1,864,721 | Sep 23, 2020, 05:09 PM |
Naschitz Anat | Director | Sep 21, 2020 | Sale | $28.00 | 275,000 | 7,700,000 | 1,864,721 | Sep 23, 2020, 05:04 PM |
RA CAPITAL MANAGEMENT, L.P. | Director | Sep 17, 2020 | Buy | $28.00 | 1,300,000 | 36,400,000 | 4,736,214 | Sep 21, 2020, 04:30 PM |
Longitude Capital Partners III, LLC | 10% Owner | Jul 10, 2020 | Buy | $27.50 | 109,090 | 2,999,975 | 2,600,877 | Jul 14, 2020, 08:11 PM |
Grunberg Gregory | Director | Jul 10, 2020 | Buy | $27.50 | 109,090 | 2,999,975 | 2,600,877 | Jul 14, 2020, 08:08 PM |
RA CAPITAL MANAGEMENT, L.P. | Director | Jul 08, 2020 | Buy | $27.50 | 275,000 | 7,562,500 | 3,436,214 | Jul 10, 2020, 04:32 PM |
Kariv Tomer | Director | Nov 11, 2019 | Buy | $16.00 | 250,000 | 4,000,000 | 250,000 | Nov 13, 2019, 07:10 PM |
Naschitz Anat | Director | Nov 11, 2019 | Buy | $16.00 | 837,500 | 13,400,000 | 724,363 | Nov 13, 2019, 07:07 PM |
RA CAPITAL MANAGEMENT, L.P. | Director | Nov 11, 2019 | Buy | $16.00 | 1,500,000 | 24,000,000 | 1,500,000 | Nov 13, 2019, 07:06 PM |
Grunberg Gregory | Director | Nov 11, 2019 | Buy | $16.00 | 575,000 | 9,200,000 | 575,000 | Nov 13, 2019, 07:04 PM |
Hayden Michael R | Director | Nov 11, 2019 | Buy | $16.00 | 18,750 | 300,000 | 18,750 | Nov 13, 2019, 07:02 PM |
Longitude Capital Partners III, LLC | 10% Owner | Nov 11, 2019 | Buy | $16.00 | 575,000 | 9,200,000 | 575,000 | Nov 13, 2019, 07:02 PM |
ORBIMED ADVISORS LLC | Director | Nov 11, 2019 | Buy | $16.00 | 837,500 | 13,400,000 | 724,363 | Nov 13, 2019, 07:00 PM |
Owner | Relationship | Date | Value($) |
Mansbach Harry H | Chief Medical Officer | 02/05/2022 | 7,128 |
Martins Ryan | Chief Financial Officer | 02/05/2022 | 5,345 |
PALEKAR ROHAN | Chief Executive Officer | 02/05/2022 | 21,380 |
Le-Nguyen Quoc | See Remarks | 02/05/2022 | 7,128 |
Waisbourd Ram | See Remarks | 02/01/2022 | 13,510 |
Waisbourd Ram | See Remarks | 02/01/2022 | 39,900 |
PALEKAR ROHAN | Chief Executive Officer | 01/27/2022 | 37,500 |
PALEKAR ROHAN | Chief Executive Officer | 01/28/2022 | 15,350 |
ORBIMED ADVISORS LLC | 10% Owner | 01/26/2022 | 180,019 |
ORBIMED ADVISORS LLC | 10% Owner | 01/25/2022 | 412,364 |
Waisbourd Ram | See Remarks | 12/16/2021 | 13,510 |
Waisbourd Ram | See Remarks | 12/16/2021 | 80,360 |
Waisbourd Ram | See Remarks | 11/16/2021 | 13,510 |
Waisbourd Ram | See Remarks | 11/16/2021 | 115,430 |
Waisbourd Ram | See Remarks | 10/18/2021 | 13,510 |
Waisbourd Ram | See Remarks | 10/18/2021 | 122,430 |
Waisbourd Ram | See Remarks | 09/16/2021 | 13,510 |
Waisbourd Ram | See Remarks | 09/16/2021 | 136,220 |
Waisbourd Ram | See Remarks | 08/16/2021 | 13,510 |
Waisbourd Ram | See Remarks | 08/16/2021 | 127,960 |
Waisbourd Ram | See Remarks | 07/16/2021 | 13,510 |
Waisbourd Ram | See Remarks | 07/16/2021 | 117,600 |
PALEKAR ROHAN | Chief Executive Officer | 07/07/2021 | 85,350 |
PALEKAR ROHAN | Chief Executive Officer | 07/08/2021 | 32,500 |
RA CAPITAL MANAGEMENT, L.P. | Director | 06/02/2021 | 415,530 |
Grunberg Gregory | Director | 04/21/2021 | 23,460 |
Waisbourd Ram | See Remarks | 03/16/2021 | 13,510 |
Waisbourd Ram | See Remarks | 03/16/2021 | 169,400 |
Hayden Michael R | Director | 02/23/2021 | 172,236 |
Waisbourd Ram | See Remarks | 02/16/2021 | 13,510 |
Waisbourd Ram | See Remarks | 02/16/2021 | 163,730 |
Waisbourd Ram | See Remarks | 01/19/2021 | 13,510 |
Waisbourd Ram | See Remarks | 01/19/2021 | 148,120 |
Waisbourd Ram | See Remarks | 12/16/2020 | 13,510 |
Waisbourd Ram | See Remarks | 12/16/2020 | 189,280 |
Le-Nguyen Quoc | See Remarks | 11/16/2020 | 14,144 |
Le-Nguyen Quoc | See Remarks | 11/16/2020 | 127,844 |
Waisbourd Ram | COO and Chief Business Officer | 11/16/2020 | 13,510 |
Waisbourd Ram | COO and Chief Business Officer | 11/16/2020 | 191,730 |
ORBIMED ADVISORS LLC | Director | 09/21/2020 | 7,700,000 |
Naschitz Anat | Director | 09/21/2020 | 7,700,000 |
RA CAPITAL MANAGEMENT, L.P. | Director | 09/17/2020 | 36,400,000 |
Longitude Capital Partners III, LLC | 10% Owner | 07/10/2020 | 2,999,975 |
Grunberg Gregory | Director | 07/10/2020 | 2,999,975 |
RA CAPITAL MANAGEMENT, L.P. | Director | 07/08/2020 | 7,562,500 |
Kariv Tomer | Director | 11/11/2019 | 4,000,000 |
Naschitz Anat | Director | 11/11/2019 | 13,400,000 |
RA CAPITAL MANAGEMENT, L.P. | Director | 11/11/2019 | 24,000,000 |
Grunberg Gregory | Director | 11/11/2019 | 9,200,000 |
Hayden Michael R | Director | 11/11/2019 | 300,000 |
Longitude Capital Partners III, LLC | 10% Owner | 11/11/2019 | 9,200,000 |
ORBIMED ADVISORS LLC | Director | 11/11/2019 | 13,400,000 |
Period of Report: 12/31/2021
10-K/10-Q Filings: View